Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Independent Evaluation of the Respective Predictive Values for High-Grade Prostate Cancer of Clinical Information and RNA Biomarkers after Upfront MRI and Image-Guided Biopsies.

Roumiguié M, Ploussard G, Nogueira L, Bruguière E, Meyrignac O, Lesourd M, Péricart S, Malavaud B.

Cancers (Basel). 2020 Jan 24;12(2). pii: E285. doi: 10.3390/cancers12020285.

2.

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.

Ploussard G, Beauval JB, Renard-Penna R, Lesourd M, Manceau C, Almeras C, Gautier JR, Loison G, Portalez D, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

J Clin Med. 2020 Jan 15;9(1). pii: E225. doi: 10.3390/jcm9010225.

3.

Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.

Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G.

Urol Oncol. 2020 Jan 13. pii: S1078-1439(19)30505-8. doi: 10.1016/j.urolonc.2019.12.018. [Epub ahead of print]

PMID:
31948932
4.

Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

Urology. 2019 Dec 30. pii: S0090-4295(19)31124-0. doi: 10.1016/j.urology.2019.10.039. [Epub ahead of print]

PMID:
31899229
5.

Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.

Ploussard G, Manceau C, Beauval JB, Lesourd M, Almeras C, Gautier JR, Loison G, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

World J Urol. 2019 Dec 14. doi: 10.1007/s00345-019-03053-6. [Epub ahead of print]

PMID:
31838560
6.

Exclusive B-cell phenotype of primary prostatic lymphomas. A potential role of chronic prostatitis.

Péricart S, Syrykh C, Amara N, Franchet C, Malavaud B, Gaulard P, Girard JP, Ysebaert L, Laurent C, Brousset P.

Histopathology. 2019 Dec 11. doi: 10.1111/his.14045. [Epub ahead of print]

PMID:
31825109
7.

Bricker ileal conduit diversion in 10 steps.

Martínez-Gómez C, Angeles MA, Sanson C, Bernard M, Martinez A, Ferron G.

Int J Gynecol Cancer. 2020 Feb;30(2):279. doi: 10.1136/ijgc-2019-000899. Epub 2019 Dec 1. No abstract available.

PMID:
31792087
8.

Creation of a Y-shaped ileal orthotopic neobladder after an anterior pelvic exenteration in 10 logical steps.

Martínez-Gómez C, Angeles MA, Migliorelli F, Martinez A, Bernard M, Ferron G.

Int J Gynecol Cancer. 2020 Jan;30(1):152-153. doi: 10.1136/ijgc-2019-000862. Epub 2019 Oct 23. No abstract available.

PMID:
31645426
9.

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.

Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2019 Oct 14. doi: 10.1007/s00345-019-02973-7. [Epub ahead of print]

PMID:
31612251
10.

The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Roumiguié M, Fossati N, Stabile A, Beauval JB, Malavaud B, Scuderi S, Barletta F, Moschini M, Zamboni S, Rakauskas A, Tian Z, Karakiewicz PI, De Cobelli F, Porpiglia F, Montorsi F, Briganti A.

Eur Urol. 2019 Sep 21. pii: S0302-2838(19)30694-3. doi: 10.1016/j.eururo.2019.09.005. [Epub ahead of print]

PMID:
31547938
11.

Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

J Urol. 2019 Dec;202(6):1182-1187. doi: 10.1097/JU.0000000000000418. Epub 2019 Jun 27.

PMID:
31246548
12.

Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2019 Jun 13. doi: 10.1007/s00345-019-02848-x. [Epub ahead of print]

PMID:
31197523
13.

Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases.

Morgat C, Chastel A, Molinie V, Schollhammer R, Macgrogan G, Vélasco V, Malavaud B, Fernandez P, Hindié E.

Int J Mol Sci. 2019 Apr 7;20(7). pii: E1721. doi: 10.3390/ijms20071721.

14.

Periprostatic Adipose Tissue Favors Prostate Cancer Cell Invasion in an Obesity-Dependent Manner: Role of Oxidative Stress.

Laurent V, Toulet A, Attané C, Milhas D, Dauvillier S, Zaidi F, Clement E, Cinato M, Le Gonidec S, Guérard A, Lehuédé C, Garandeau D, Nieto L, Renaud-Gabardos E, Prats AC, Valet P, Malavaud B, Muller C.

Mol Cancer Res. 2019 Mar;17(3):821-835. doi: 10.1158/1541-7786.MCR-18-0748. Epub 2019 Jan 3.

PMID:
30606769
15.

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.

Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, Decaussin-Petrucci M, Dubreuil-Chambardel M, Magaud L, Remontet L, Ruffion A, Colombel M, Crouzet S, Schott AM, Lemaitre L, Rabilloud M, Grenier N; MRI-FIRST Investigators.

Lancet Oncol. 2019 Jan;20(1):100-109. doi: 10.1016/S1470-2045(18)30569-2. Epub 2018 Nov 21.

PMID:
30470502
16.

Prospective evaluation of the performances of narrow-band imaging flexible videoscopy relative to white-light imaging flexible videoscopy, in patients scheduled for transurethral resection of a primary NMIBC.

Dalgaard LP, Zare R, Gaya JM, Redorta JP, Roumiguié M, Filleron T, Malavaud B.

World J Urol. 2019 Aug;37(8):1615-1621. doi: 10.1007/s00345-018-2537-7. Epub 2018 Oct 26.

PMID:
30367204
17.

A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A.

Eur Urol. 2019 Mar;75(3):506-514. doi: 10.1016/j.eururo.2018.10.012. Epub 2018 Oct 17.

PMID:
30342844
18.

Comment on "Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy".

Malavaud B, Daniel G, Ranty ML.

Histopathology. 2019 Feb;74(3):530-532. doi: 10.1111/his.13766. No abstract available.

PMID:
30291642
19.

SIU-ICUD on bladder cancer: pathology.

Compérat E, Babjuk M, Algaba F, Amin M, Brimo F, Grignon D, Hansel D, Hes O, Malavaud B, Reuter V, van der Kwast T.

World J Urol. 2019 Jan;37(1):41-50. doi: 10.1007/s00345-018-2466-5. Epub 2018 Sep 14.

PMID:
30218308
20.

Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies.

Covin B, Roumiguié M, Quintyn-Ranty ML, Graff P, Khalifa J, Aziza R, Ploussard G, Portalez D, Malavaud B.

World J Urol. 2019 Feb;37(2):269-275. doi: 10.1007/s00345-018-2459-4. Epub 2018 Aug 25.

PMID:
30145777

Supplemental Content

Loading ...
Support Center